Citations

Showing 10 of 107850 citations.

A Tissue-Engineered Stent for Cell-Based Vascular Gene Transfer
Panetta, Carmelo , Miyauchi, Katsumi , Simari, Robert D., Holmes, David R. , Schwartz, Robert S., Caplice, Noel M. , Berry, David

Mayo Clinic

Human Gene Therapy | July 26, 2002 | Volume: 13 | Issue: 3 | Pages: 433-441

10.1089/10430340252792567 | PMID 11860710 Get It

A Hyperfusogenic Gibbon Ape Leukemia Envelope Glycoprotein: Targeting of a Cytotoxic Gene by Ligand Display
Chapel‐Fernandes, Sylvie , Chadwick, M P, Bullough, Frances J., Cosset, François‐Loïc , Fielding, Adele K. , Russell, Stephen J.

Mayo Clinic

Human Gene Therapy | July 26, 2002 | Volume: 11 | Issue: 6 | Pages: 817-826

10.1089/10430340050015437 | PMID 10779159 Get It

Cost Effectiveness of Treatment for Benign Prostatic Hyperplasia: An Economic Model for Comparison of Medical, Minimally Invasive, and Surgical Therapy
Manyak, Michael J. , Ackerman, Stacey J. , Blute, Michael L., Rein, Alison, Buesterien, Kathleen, Sullivan, Erin , Tanio, Craig P, Strauss, Michael J.

Mayo Clinic

Journal of Endourology | July 26, 2002 | Volume: 16 | Issue: 1 | Pages: 51-56

10.1089/089277902753483736 | PMID 11890452 Get It

Prevention of Malaria in Children
Fischer, Philip R. , Bialek, Ralf

Mayo Clinic

Clinical Infectious Diseases | July 26, 2002 | Volume: 34 | Issue: 4 | Pages: 493-498

10.1086/338257 | PMID 11797176 Get It

Dual Effects of Adp and Adenylylimidodiphosphate on Cftr Channel Kinetics Show Binding to Two Different Nucleotide Binding Sites
Weinreich, Frank, Riordan, John R., Nagel, Georg

Mayo Clinic

The Journal of General Physiology | July 26, 2002 | Volume: 114 | Issue: 1 | Pages: 55-70

10.1085/jgp.114.1.55 | PMID 10398692 Get It

The CFTR chloride channel is regulated by phosphorylation by protein kinases, especially PKA, and by nucleotides interacting with the two nucleotide binding domains, NBD-A and NBD-B. Giant excised inside-out membrane patches from Xenopus oocytes expressing human epithelial cystic fibrosis transmembrane conductance regulator (CFTR) were tested for their chloride conductance in response to the application of PKA and nucleotides. Rapid changes in the concentration of ATP, its nonhydrolyzable analogue adenylylimidodiphosphate (AMP-PNP), its photolabile derivative ATP-P3-[1-(2-nitrophenyl)ethyl]ester, or ADP led to changes in chloride conductance with characteristic time constants, which reflected interaction of CFTR with these nucleotides. The conductance changes of strongly phosphorylated channels were slower than those of partially phosphorylated CFTR. AMP-PNP decelerated relaxations of conductance increase and decay, whereas ATP-P3-[1-(2-nitrophenyl)ethyl]ester only decelerated the conductance increase upon ATP addition. ADP decelerated the conductance increase upon ATP addition and accelerated the conductance decay upon ATP withdrawal. The results present the first direct evidence that AMP-PNP binds to two sites on the CFTR. The effects of ADP also suggest two different binding sites because of the two different modes of inhibition observed: it competes with ATP for binding (to NBD-A) on the closed channel, but it also binds to channels opened by ATP, which might either reflect binding to NBD-A (i.e., product inhibition in the hydrolysis cycle) or allosteric binding to NBD-B, which accelerates the hydrolysis cycle at NBD-A.
Ligand-insensitive State of Cardiac ATP-sensitive K+ Channels
Alekseev, Alexey E., Brady, Peter A. , Terzic, André

Mayo Clinic

The Journal of General Physiology | July 26, 2002 | Volume: 111 | Issue: 2 | Pages: 381-394

10.1085/jgp.111.2.381 | PMID 9450949 Get It

The mechanism by which ATP-sensitive K+ (KATP) channels open in the presence of inhibitory concentrations of ATP remains unknown. Herein, using a four-state kinetic model, we found that the nucleotide diphosphate UDP directed cardiac KATP channels to operate within intraburst transitions. These transitions are not targeted by ATP, nor the structurally unrelated sulfonylurea glyburide, which inhibit channel opening by acting on interburst transitions. Therefore, the channel remained insensitive to ATP and glyburide in the presence of UDP. “Rundown” of channel activity decreased the efficacy with which UDP could direct and maintain the channel to operate within intraburst transitions. Under this condition, the channel was sensitive to inhibition by ATP and glyburide despite the presence of UDP. This behavior of the KATP channel could be accounted for by an allosteric model of ligand-channel interaction. Thus, the response of cardiac KATP channels towards inhibitory ligands is determined by the relative lifetime the channel spends in a ligand-sensitive versus -insensitive state. Interconversion between these two conformational states represents a novel basis for KATP channel opening in the presence of inhibitory concentrations of ATP in a cardiac cell.
Permeability of Wild-Type and Mutant Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels to Polyatomic Anions
Linsdell, Paul , Tabcharani, Joseph A., Rommens, Johanna M. , Hou, Yue-xian, Chang, Xiu-Bao, Tsui, Lap-Chee, Riordan, John R., Tsui, Lap‐Chee, Hanrahan, John W.

Mayo Clinic

The Journal of General Physiology | July 26, 2002 | Volume: 110 | Issue: 4 | Pages: 355-364

10.1085/jgp.110.4.355 | PMID 9379168 Get It

Permeability of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel to polyatomic anions of known dimensions was studied in stably transfected Chinese hamster ovary cells by using the patch clamp technique. Biionic reversal potentials measured with external polyatomic anions gave the permeability ratio (PX/PCl) sequence NO3− > Cl− > HCO3− > formate > acetate. The same selectivity sequence but somewhat higher permeability ratios were obtained when anions were tested from the cytoplasmic side. Pyruvate, propanoate, methane sulfonate, ethane sulfonate, and gluconate were not measurably permeant (PX/PCl < 0.06) from either side of the membrane. The relationship between permeability ratios from the outside and ionic diameters suggests a minimum functional pore diameter of ∼5.3 Å. Permeability ratios also followed a lyotropic sequence, suggesting that permeability is dependent on ionic hydration energies. Site-directed mutagenesis of two adjacent threonines in TM6 to smaller, less polar alanines led to a significant (24%) increase in single channel conductance and elevated permeability to several large anions, suggesting that these residues do not strongly bind permeating anions, but may contribute to the narrowest part of the pore.
The Vav–Rac1 Pathway in Cytotoxic Lymphocytes Regulates the Generation of Cell-mediated Killing
Billadeau, Daniel D. , Brumbaugh, Kathryn M., Dick, Christopher J., Schoon, Renee A., Bustelo, Xosé R. , Leibson, Paul J.

Mayo Clinic

The Journal of Experimental Medicine | July 26, 2002 | Volume: 188 | Issue: 3 | Pages: 549-559

10.1084/jem.188.3.549 | PMID 9687532 Get It

The Rac1 guanine nucleotide exchange factor, Vav, is activated in hematopoietic cells in response to a large variety of stimuli. The downstream signaling events derived from Vav have been primarily characterized as leading to transcription or transformation. However, we report here that Vav and Rac1 in natural killer (NK) cells regulate the development of cell-mediated killing. There is a rapid increase in Vav tyrosine phosphorylation during the development of antibody-dependent cellular cytotoxicity and natural killing. In addition, overexpression of Vav, but not of a mutant lacking exchange factor activity, enhances both forms of killing by NK cells. Furthermore, dominant-negative Rac1 inhibits the development of NK cell–mediated cytotoxicity by two mechanisms: (a) conjugate formation between NK cells and target cells is decreased; and (b) those NK cells that do form conjugates have decreased ability to polarize their granules toward the target cell. Therefore, our results suggest that in addition to participating in the regulation of transcription, Vav and Rac1 are pivotal regulators of adhesion, granule exocytosis, and cellular cytotoxicity.
CD4 Regulates Susceptibility to Fas ligand– and Tumor Necrosis Factor–mediated Apoptosis
Algeciras, Alicia, Dockrell, David H. , Payá, Carlos V., Lynch, David H.

Mayo Clinic

The Journal of Experimental Medicine | July 26, 2002 | Volume: 187 | Issue: 5 | Pages: 711-720

10.1084/jem.187.5.711 | PMID 9480981 Get It

The current knowledge of CD4 function is limited to its role as a necessary coreceptor in TCR-initiated signaling. We have investigated whether CD4 regulates additional T cell functions. Using human primary resting CD4+ T cells, we demonstrate that CD4 activation is sufficient to induce lymphocyte death. Immediately after CD4 cross-linking, CD4+ T cells are rendered susceptible to apoptosis mediated by TNF or FasL. This, together with the concomitant induction of FasL within the same population, results in significant CD4+ T cell death in vitro. The CD4-dependent induction of susceptibility to apoptosis that is mediated by TNF or FasL is protein synthesis independent but phosphorylation dependent. After CD4 activation, PKC regulates susceptibility to apoptosis mediated by FasL but not the induction of susceptibility to TNF-dependent apoptosis. Moreover, significant differences between CD3 and CD4 activation were observed with regards to the kinetics of induction of CD4+ T cell susceptibility to FasL- and TNF-mediated apoptosis. Altogether, these results provide a model with which to study the molecular mechanisms regulating lymphocyte survival after CD4 activation, and highlight the potential role of CD4 in controlling lymphocyte apoptosis under physiological conditions or in disease states such as HIV infection.
Functional Role for Syk Tyrosine Kinase in Natural Killer Cell–mediated Natural Cytotoxicity
Brumbaugh, Kathryn M., Binstadt, Bryce A. , Billadeau, Daniel D. , Schoon, Renee A., Dick, Christopher J., Ten, Rosa, Leibson, Paul J.

Mayo Clinic

The Journal of Experimental Medicine | July 26, 2002 | Volume: 186 | Issue: 12 | Pages: 1965-1974

10.1084/jem.186.12.1965 | PMID 9396765 Get It

Natural killer (NK) cells are named based on their natural cytotoxic activity against a variety of target cells. However, the mechanisms by which sensitive targets activate killing have been difficult to study due to the lack of a prototypic NK cell triggering receptor. Pharmacologic evidence has implicated protein tyrosine kinases (PTKs) in natural killing; however, Lck-deficient, Fyn-deficient, and ZAP-70–deficient mice do not exhibit defects in natural killing despite demonstrable defects in T cell function. This discrepancy implies the involvement of other tyrosine kinases. Here, using combined biochemical, pharmacologic, and genetic approaches, we demonstrate a central role for the PTK Syk in natural cytotoxicity. Biochemical analyses indicate that Syk is tyrosine phosphorylated after stimulation with a panel of NK-sensitive target cells. Pharmacologic exposure to piceatannol, a known Syk family kinase inhibitor, inhibits natural cytotoxicity. In addition, gene transfer of dominant-negative forms of Syk to NK cells inhibits natural cytotoxicity. Furthermore, sensitive targets that are rendered NK-resistant by major histocompatibility complex (MHC) class I transfection no longer activate Syk. These data suggest that Syk activation is an early and requisite signaling event in the development of natural cytotoxicity directed against a variety of cellular targets.